LFLYW vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, AONC, and APLMW
Should you be buying Leafly stock or one of its competitors? The main competitors of Leafly include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), American Oncology Network (AONC), and Apollomics (APLMW). These companies are all part of the "medical" sector.
Leafly (NASDAQ:LFLYW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, community ranking, profitability, institutional ownership, analyst recommendations, earnings and valuation.
In the previous week, Leafly and Leafly both had 1 articles in the media. Leafly's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
Leafly and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
Leafly beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.
Get Leafly News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFLYW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFLYW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LFLYW vs. The Competition
Related Companies and Tools
